FLHL.F Stock Overview
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Filament Health Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.036 |
52 Week High | US$0.20 |
52 Week Low | US$0.035 |
Beta | 1.23 |
1 Month Change | -33.21% |
3 Month Change | -47.55% |
1 Year Change | -39.53% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -87.89% |
Recent News & Updates
Recent updates
Shareholder Returns
FLHL.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -9.0% | 1.2% | 0.4% |
1Y | -39.5% | 25.8% | 28.8% |
Return vs Industry: FLHL.F underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.
Return vs Market: FLHL.F underperformed the US Market which returned 29.5% over the past year.
Price Volatility
FLHL.F volatility | |
---|---|
FLHL.F Average Weekly Movement | 23.9% |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FLHL.F's share price has been volatile over the past 3 months.
Volatility Over Time: FLHL.F's weekly volatility has decreased from 48% to 24% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 11 | Ben Lightburn | https://filament.health |
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company. The company propagates psychedelic plants and fungi; conducts genetic research; develops manufacturing technology; generates intellectual property; conducts in-house trials; and distributes drug candidates to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Filament Health Corp. Fundamentals Summary
FLHL.F fundamental statistics | |
---|---|
Market cap | US$7.69m |
Earnings (TTM) | -US$11.96m |
Revenue (TTM) | US$419.98k |
18.3x
P/S Ratio-0.6x
P/E RatioIs FLHL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FLHL.F income statement (TTM) | |
---|---|
Revenue | CA$569.97k |
Cost of Revenue | CA$0 |
Gross Profit | CA$569.97k |
Other Expenses | CA$16.80m |
Earnings | -CA$16.23m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.077 |
Gross Margin | 100.00% |
Net Profit Margin | -2,848.09% |
Debt/Equity Ratio | 38.0% |
How did FLHL.F perform over the long term?
See historical performance and comparison